Evidence map›Paper›PMID 32524756›Full record

ArticleAmerican journal of medical genetics. Part A2020

Differentiating molecular etiologies of Angelman syndrome through facial phenotyping using deep learning.

Diego A Gomez, Lynne M Bird, Nicole Fleischer, Omar A Abdul-Rahman

Open access · greenAbstract read
In one paragraph

Article in American journal of medical genetics. Part A, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Diego A GomezCollege of Arts and Sciences, Creighton University, Omaha, Nebraska, USA.ORCID https://orcid.org/0000-0001-7818-3546
Lynne M BirdDepartment of Pediatrics, University of California San Diego, San Diego, California, USA.
Nicole FleischerFDNA Inc., Boston, Massachusetts, USA.
Omar A Abdul-RahmanDepartment of Genetic Medicine, Munroe-Meyer Institute, University of Nebraska Medical Center, Omaha, Nebraska, USA.ORCID https://orcid.org/0000-0002-1020-9989
Creighton University · USNebraska Medical Center · USUniversity of California San Diego · USUniversity of Massachusetts Boston · US

Funding

Training and Career Development ComponentU54HD061222 · NICHD · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI PERCY, ALAN KENNETH · 2009 to 2019
$12.4M
RARE DISEASE CRC FOR NEW THERAPIES AND NEW DIAGNOSTICSU54RR019478 · NCRR · BAYLOR COLLEGE OF MEDICINE · PI BEAUDET, ARTHUR L. · 2003 to 2008
$7.3M
NCRR NIH HHS U54 RR019478NICHD NIH HHS U54 HD061222NIH HHS U54 HD061222NIH HHS U54 RR019478
6 · The paper itself

Abstract

Angelman syndrome (AS) is caused by several genetic mechanisms that impair the expression of maternally-inherited UBE3A through deletions, paternal uniparental disomy (UPD), UBE3A pathogenic variants, or imprinting defects. Current methods of differentiating the etiology require molecular testing, which is sometimes difficult to obtain. Recently, computer-based facial analysis systems have been used to assist in identifying genetic conditions based on facial phenotypes. We sought to understand if the facial-recognition system DeepGestalt could find differences in phenotype between molecular subtypes of AS. Images and molecular data on 261 individuals with AS ranging from 10 months through 32 years were analyzed by DeepGestalt in a cross-validation model with receiver operating characteristic (ROC) curves generated. The area under the curve (AUC) of the ROC for each molecular subtype was compared and ranked from least to greatest differentiable phenotype. We determined that DeepGestalt demonstrated a high degree of discrimination between the deletion subtype and UPD or imprinting defects, and a lower degree of discrimination with the UBE3A pathogenic variants subtype. Our findings suggest that DeepGestalt can recognize subclinical differences in phenotype based on etiology and may provide decision support for testing.

Indexed as

Deep LearningAdolescentAdultAngelman SyndromeChildChild, PreschoolFaceFemaleGenomic ImprintingHumansInfantMaleMaternal InheritancePhenotypeUbiquitin-Protein LigasesUniparental DisomyUbiquitin-Protein LigasesAngelman syndromeartificial intelligencedeep learningfacial phenotypingimprinting defectsuniparental disomy

Identifiers

PMID32524756
PMCPMC12096522
OpenAlexW3033362069

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.